GI
ORKA

GAMMA Investing’s Oruka Therapeutics ORKA Stock Holding History

GAMMA Investing’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
124
+41
+49% +$2.73K ﹤0.01% 3123
2026
Q1 		$4.07K Sell
83
-18
-18% -$626 ﹤0.01% 3440
2025
Q4 		$3.06K Buy
+101
New +$2.81K ﹤0.01% 3469

Other funds holding ORKA

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

GAMMA Investing's ORKA Position: Q2 2026 in Review

GAMMA Investing increased its Oruka Therapeutics (ORKA) stake by 49% in Q2 2026, buying an estimated $2.73K and bringing the position to 124 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

GAMMA Investing first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • GAMMA Investing held 124 shares of Oruka Therapeutics worth $11.8K as of Q2 2026.
  • GAMMA Investing bought 41 Oruka Therapeutics shares in Q2 2026, an estimated $2.73K.
  • Oruka Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3123 holding.
  • GAMMA Investing first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 15 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.